Serge Herson

Centre De Référence Des Pathologies Neuromusculaires Paris Est, UPMC, APHP, UMR 974, DHU I2B
Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial.

Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial.

Journal: PloS one

Published: November 16, 2014

Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.

Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.

Journal: Medicine

Published: May 07, 2014

Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: implications for therapeutic trials.

Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: implications for therapeutic trials.

Journal: Neuromuscular disorders : NMD

Published: February 14, 2014

Th1 response and systemic treg deficiency in inclusion body myositis.

Th1 response and systemic treg deficiency in inclusion body myositis.

Journal: PloS one

Published: September 20, 2013

Attitudes and expectations of patients with neuromuscular diseases about their participation in a clinical trial.

Attitudes and expectations of patients with neuromuscular diseases about their participation in a clinical trial.

Journal: Revue neurologique

Published: March 08, 2013

HTLV-1-associated inflammatory myopathies: low proviral load and moderate inflammation in 13 patients from West Indies and West Africa.

HTLV-1-associated inflammatory myopathies: low proviral load and moderate inflammation in 13 patients from West Indies and West Africa.

Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Published: September 12, 2012

Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use.

Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use.

Journal: The Journal of rheumatology

Published: August 04, 2012

Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort study.

Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort study.

Journal: PloS one

Published: April 30, 2012

Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease.

Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease.

Journal: Medicine

Published: March 07, 2012

Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositis.

Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositis.

Journal: Neuromuscular disorders : NMD

Published: February 22, 2012

Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositis.

Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositis.

Journal: Neuromuscular disorders : NMD

Published: January 17, 2012

A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C.

A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C.

Journal: Brain : a journal of neurology

Published: January 14, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026